References
- Salman R, Hornsby J, Wright LJ, et al. Treatment of subclavian artery stenosis: a case series. Int J Surg Case Rep. 2016;19:69–74.
- Saha T, Naqvi SY, Ayah OA, et al. Subclavian artery disease: diagnosis and therapy. Am J Med. 2017;130(4):409–416.
- Aboyans V, Criqui MH, McDermott MM, et al. The vital prognosis of subclavian stenosis. J Am Coll Cardiol. 2007;49(14):1540–1545.
- Stone PA, Srivastiva M, Campbell JE, et al. Diagnosis and treatment of subclavian artery occlusive disease. Expert Rev Cardiovasc Ther. 2010;8(9):1275–1282.
- Clark CE, Taylor RS, Shore AC, et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012;379(9819):905–914.
- Williams B, Mancia G, Spiering W, et al. Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Pressure. 2018;27(6):314–340.
- Aboyans V, Ricco J-B, Bartelink M-L, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017;39(9):763–816.
- Fowkes FG, Price JF, Stewart MC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010;303(9):841–848.
- Mach F, Baigent C, Catapano AL, ESC Scientific Document Group, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111–188.